Comparative gene editing reduces dopamine receptor levels across rodent species
Sonia Corbett Karkare, Dario Aspesi, Keith M. Garner, Evelien H.S. Schut, H. Elliott Albers, Frank Julius Meye, Malavika Murugan, Arjen J. Boender
This paper develops a CRISPR/Cas9-based method to reduce dopamine receptor levels in multiple rodent species, enabling comparative studies of neural mechanisms.
bioRxiv · Oct 21, 2025 · PreprintNeuroscience